-+ 0.00%
-+ 0.00%
-+ 0.00%

Quest Diagnostics Raises FY2026 GAAP EPS Guidance from $9.45-$9.65 to $9.58-$9.78 vs $9.43 Est.

Benzinga·04/21/2026 11:02:28
Listen to the news
Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.45-$9.65 to $9.58-$9.78 vs $9.43 analyst estimate..